SCHEMBL17400435

SCHEMBL17400435

Cc1ccc(S(=O)(=O)NN=C2CC(=O)c3ccccc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ NPSR1 Q6W5P4 3/20 0.53
▸ HTT P42858 1/20 0.53
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ MAPT P10636 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ NOD2 Q9HC29 1/20 0.47
▸ KDM4E B2RXH2 3/20 0.46
▸ F2 P00734 1/20 0.43
▸ PRSS1 P07477 1/20 0.43
▸ PRSS2 P07478 1/20 0.43
▸ PRSS3 P35030 1/20 0.43
▸ PTPRC P08575 1/20 0.43
▸ CA12 O43570 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17540298 1.00 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL17540297 0.78 ALDH1A1 (0.64) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL4054935 0.76 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL6081531 0.76 ALDH1A1 (0.77) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL2599212 0.75 PTPRC (0.52) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL2599210 0.75 PTPRC (0.52) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL10815369 0.75 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AHTTL3MBTL1
SCHEMBL18212645 0.74 ALDH1A1 (0.60) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL18211742 0.74 ALDH1A1 (0.60) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL2243639 0.73 ALDH1A1 (0.54) ALDH1A1MEN1KMT2AHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9923143-B2 Fullerene derivative, organic solar cell using same, and manufacturing method thereof LG CHEM, LTD. (KR) 2018-03-20 — — US disclosed
US-20160056383-A1 FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND MANUFACTURING METHOD THEREOF LG CHEM, LTD. (KR) 2016-02-25 — — US disclosed
EP-2962992-A1 FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND MANUFACTURING METHOD THEREOF LG Chem, Ltd. (KR) 2016-01-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160056383-A1 FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND MANUFACTURING METHOD THEREOF FTO, SUN2, CRY2 ALDH1A1 2218/4885MEN1 822/4885KMT2A 1386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback